20101004
 Drug Firms Face Bribery Probe --- Justice Department, SEC Seek Information From Companies on Payments to Overseas Officials   By Rothfeld, Michael, The Wall Street Journal,  Oct 5, 2010  Letters from the government to one of the companies, which were reviewed by The Wall Street Journal, identified four types of possible violations: bribing government-employed doctors to purchase drugs; paying company sales agents commissions that are passed along to government doctors; paying hospital committees to approve drug purchases; and paying regulators to win drug approvals.   
